By shutting South Africa out of its overseas funding for the roll-out of the revolutionary six-monthly HIV prevention jab ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best pharma stocks to invest in. Cantor Fitzgerald analyst Carter Gould ...

An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of ...

Viver Health is proud to announce the introduction of Your Guide to Managing Symptoms from Metastatic Breast Cancer Treatment, a take-home, evidence-based educational resource designed to help ...

Malawi on Thursday, December 4, authorised the use of the injectable HIV prevention drug lenacapavir, becoming the fourth ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsAndrew Dickinson - ...

Despite advances in HIV treatment, the epidemic still disproportionately affects Black communities in the South, particularly ...

BAY AREA LEADERS AND GAY RIGHTS advocates gathered in San Francisco to honor community members and commemorate World AIDS Day.  Tweed suits and feathered Bay Area leaders and LGBTQ advocates gathered ...

Debt Management: Gilead Sciences's debt-to-equity ratio is below the industry average. With a ratio of 1.16, the company ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

Singer Elton John praised bipartisan efforts, including from the Trump administration, to end the HIV pandemic by 2030, during a recent Variety interview.

A new manufacturing process is on track to make developing HIV-prevention medication more affordable and potentially decrease new HIV infections in hard-hit countries.